Research Open Terminal →

← Unusual insider activity · Company hub

REGN Regeneron Pharmaceuticals Inc

Insider figures are trailing 90 days, open-market Form 4 only. Institutional figures are the latest reported quarter. These windows are not simultaneous.

-$41.8M net selling - trailing 90 days

0 buyers - 10 unique sellers

Historical context: most recent complete month (2026-10) is the 2nd percentile of this ticker's monthly net P/S flow over 25 complete months. Lower percentiles are more selling; higher are more buying. P10–P90: -$2.7M to $0.

8 accumulating - 6 trimming - 0 unchanged

14 comparable institutions - Q2 2026

open-market Form 4 only - grants, exercises, tax withholding excluded. ~ derived from SEC-reported shares x price.

Insider net $ (monthly)open-market Form 4 only - grants, exercises, tax withholding excluded$50.0M$25.0M$0-$25.0M-$50.0M2024-10 -$1.1M2024-11 -$845K2024-12 $02025-01 $02025-02 $02025-03 $02025-04 $02025-05 $02025-06 $02025-07 $02025-08 $02025-09 $02025-10 -$4.3M2025-11 -$851K2025-12 $02026-01 -$1.2M2026-02 -$2.9M2026-03 -$53K2026-04 -$72K2026-05 -$55K2026-06 $02026-07 -$130K2026-08 -$960K2026-09 -$2.3M2026-10 -$6.2M2026-11 -$32.3MInstitutional shares (majority-gated quarters)50.0M25.0M02025-Q4 34.4M sh2026-Q1 25.2M sh2026-Q2 24.1M shOct 24Dec 24Feb 25Apr 25Jun 25Aug 25Oct 25Dec 25Feb 26Apr 26Jun 26Aug 26Oct 26Q4 2025Q1 2026Q2 2026~ derived from SEC-reported shares x price. Hatched: excluded (implausible price) or unpriced.

Who is responsible

Insider Role Net activity Rows
SING GEORGE L — -~$20.4M 9
POON CHRISTINE A — -~$7.6M 6
LAROSA JOSEPH J EVP General Counsel and Secret -~$4.3M 2
MURPHY ANDREW J Co-Chief Scientific Officer -~$3.2M 27
McCourt Marion EVP Commercial -~$2.0M 2
BROWN MICHAEL S — -~$1.7M 1
McCourt Marion EVP Commercial -~$1.0M 1
Guarini Kathryn — -~$0.7M 2
Zoghbi Huda Y — -~$0.6M 1
Guarini Kathryn — -~$0.4M 1

Transactions

Date Insider Role Type Shares Price Value
November 2, 2026 SING GEORGE L — 9 reported sale rows 21129 — ~$20.4M
November 2, 2026 POON CHRISTINE A — 6 reported sale rows 7830 — ~$7.6M
November 2, 2026 LAROSA JOSEPH J EVP General Counsel and Secret 2 reported sale rows 4466 — ~$4.3M
October 30, 2026 BROWN MICHAEL S — S -1929 875 ~$1.7M
October 30, 2026 McCourt Marion EVP Commercial S -1132 869.43 ~$1.0M
October 30, 2026 Guarini Kathryn — S -400 900 ~$0.4M
October 14, 2026 MURPHY ANDREW J Co-Chief Scientific Officer 27 reported sale rows 4147 — ~$3.2M
September 3, 2026 McCourt Marion EVP Commercial S -1131 857.39 ~$1.0M
September 2, 2026 Guarini Kathryn — S -400 850 ~$0.3M
September 2, 2026 McCourt Marion EVP Commercial S -1215 850 ~$1.0M
August 10, 2026 Guarini Kathryn — S -400 800 ~$0.3M
August 10, 2026 Zoghbi Huda Y — S -800 800 ~$0.6M
July 2, 2026 RYAN ARTHUR F — S -200 650.15 ~$0.1M
May 1, 2026 RYAN ARTHUR F — 9 reported sale rows 78 — ~$55K
April 1, 2026 RYAN ARTHUR F — 8 reported sale rows 92 — ~$72K
March 2, 2026 RYAN ARTHUR F — 8 reported sale rows 67 — ~$53K
February 19, 2026 Zoghbi Huda Y — 11 reported sale rows 1638 — ~$1.3M
February 9, 2026 Pitofsky Jason SVP Controller 11 reported sale rows 2036 — ~$1.6M
February 9, 2026 RYAN ARTHUR F — 7 reported sale rows 90 — ~$70K
January 7, 2026 Bassler Bonnie L — S -1500 800 ~$1.2M
November 20, 2025 Bassler Bonnie L — S -760 750 ~$0.6M
November 7, 2025 Pitofsky Jason VP Controller S -431 651.43 ~$0.3M
October 29, 2025 POON CHRISTINE A — 6 reported sale rows 6500 — ~$4.3M
November 1, 2024 McCourt Marion EVP Commercial S -1000 844.61 ~$0.8M
October 1, 2024 RYAN ARTHUR F — 9 reported sale rows 49 — ~$51K
October 1, 2024 McCourt Marion EVP Commercial S -1000 1054.06 ~$1.1M